-
The law expands subsidized insurance coverage for families of four with incomes up to 300 percent of the federal poverty level, or about $90,000 annually.
-
Asian Americans and Pacific Islanders often develop diabetes at lower weights and younger ages than others. Doctors from these communities are pushing for earlier screenings and lifestyle changes.
-
More than half of the counties in the nation's so-called Diabetes Belt - which includes parts of north Florida - also have high rates of medical debt among their residents, an NPR analysis found.
-
Drug shortages are growing in the United States, and experts see no clear path to resolving them. For patients, that could mean more treatment delays, medication switches and other hassles filling a prescription.
-
Online platforms are overflowing with testimonials for GLP-1s. The drugs show promise for inducing weight loss, but many aren’t FDA-approved for that use.
-
The Novo Nordisk diabetes medication was found to cause significant weight loss in users and has since become a blockbuster drug and very big business.
-
The Danish drugmaker's move follows a similar announcement by rival Eli Lilly earlier this month. More than 8 million Americans use insulin, according to the American Diabetes Association.
-
Young Black adults, Mexican Americans and other Hispanic adults experienced the greatest cardiovascular risk factors, according to a study published in the Journal of the American Medical Association.
-
Drug pricing experts predict the move will help other initiatives to bring lower-cost insulin to market and maintain pressure on Eli Lilly to keep its prices down.
-
Lilly said it will cut the list prices for its most commonly prescribed insulin, Humalog, and for another insulin, Humulin, by 70% or more in the fourth quarter, which starts in October.